Laser Treatment for Early Glaucoma Control

Glaucoma Laser Assessment of Stability and Sustainability

Recruiting N/A Interventional Study
Glaucoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
48 (estimated)
Sponsor
Twin Cities Eye Consultants · Other
Who this trial is looking for

This trial is looking for adults with early-stage glaucoma or high eye pressure. Participants will receive a laser treatment in both eyes and may get a second treatment in one eye to see if it helps lower eye pressure without daily drops.

Are You a Good Fit for This Trial?
Rules you out Congenital glaucomaAngle closure glaucomaSecondary glaucomaUncontrolled systemic disease

You may be able to join if

  • I am 40 years or older.
  • I have early-stage glaucoma or ocular hypertension.
  • I have not used any medication for my eye condition.
  • My eye pressure is between 21-35 mmHg.
  • I can read and understand the study requirements.
  • I agree to attend all follow-up exams for one year.

You may not be able to join if

  • I cannot see certain parts of my eye.
  • I have a history of other types of glaucoma.
  • I have used glaucoma medication.
  • I have had eye surgery before, except cataract surgery at least 2 years ago.
  • I have significant eye problems other than cataracts or glaucoma.
  • I have had eye inflammation or infection in the past 6 months.
  • I have had a corneal transplant or have severe corneal issues.
  • I have a serious health problem that could affect my participation.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The GLASS Study is designed to help researchers learn whether repeating a non-invasive laser treatment called DSLT (Direct Selective Laser Trabeculoplasty) can better control eye pressure in patients with early-stage glaucoma or ocular hypertension. All participants will receive the laser treatment in both eyes. After three months, one eye will be randomly selected to receive a second treatment, w…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Male and female patients aged 40 years or older * A bilateral diagnosis of ocular hypertension, glaucoma suspect, or mild primary open angle glaucoma as defined by AAO PPP * Treatment naïve with an unmedicated IOP between 21-35 mmHg, inclusive, and within +/- 3mmHg of each eye…
Contacts

Hannah Schoenecker

612-999-2020

research@tcecmn.com

CONTACT